The past couple of months have seen some quite startling Covid studies published in reputable medical journals that should be dominating our discussions in Australia about how we handle the virus as we move into its fourth year.
One of the most concerning papers – from a US government agency no less – has revealed that the serious adverse events from mRNA vaccines recorded during the original clinical trials, may have been more prevalent than first suggested.
More disturbingly, two of the papers’ esteemed authors have expressed serious concerns that the pharmaceutical companies, and the US Food and Drug Administration, are withholding...
Already a subscriber? Log in
Subscribe for just $2 a week
Try a month of The Spectator Australia absolutely free and without commitment. Not only that but – if you choose to continue – you’ll pay just $2 a week for your first year.
- Unlimited access to spectator.com.au and app
- The weekly edition on the Spectator Australia app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Comments
Don't miss out
Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.
SUBSCRIBEAlready a subscriber? Log in